A Phase II Study to examine the efficacy and safety of a new drug called Sevuparin on resolution of painful vaso-occlusive crisis in patients with sickle-cell disease.
2020-07-04
عنوان الدراسة
A Phase II Study to examine the efficacy and safety of a new drug called Sevuparin on resolution of painful vaso-occlusive crisis in patients with sickle-cell disease.
داعم الدراسة
Dilaforette AB
دواء الدراسة
Sevuparin
رقم بروتوكول الدراسة
TVOC01
حالة الدراسة
Ongoing
موقع الدراسة
King Khalid University Hospital (Riyadh), King Fahad Medical City (Riyadh), Qatif Central Hospital
مرحلة الدراسة
2
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。